Table 1 Demographic data of patients with mCNV.
| Patient follow‐up No/sex/age (years) | Duration (Months) | R/L | Refraction (D) | Position of (CNV) | BCVA | Foveal thickness (µm) | CNV size (DA) | Change of | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Final | Pre | Final | Pre | Final | Fluorescein leakage | Month | |||||
| 1/M/38 | 6 | L | −14.75 | Subfoveal | 0.09 | 0.5* | 166 | 150 | 2.07 | 1.98 | Reduced | 7 |
| 2/M/49 | 19 | L | −18.00 | Subfoveal | 0.3 | 0.6* | 245 | 147* | 0.51 | 0.43* | Reduced | 6 |
| 3/F/57 | 1 | R | −22.00 | Juxtafoveal | 0.1 | 0.5* | 202 | 119* | 0.07 | 0.03* | Resolved | 4 |
| 4/F/70 | 13 | R | −11.00† | Subfoveal | 0.3 | 0.6* | 158 | 87* | 0.12 | 0.10* | Reduced | 3.5 |
| 5/M/50 | 4 | R | −14.50 | Subfoveal | 0.5 | 0.8* | 186 | 107* | 0.12 | 0.07* | Resolved | 3 |
| 6/F/35 | 30 | L | −10.50 | Subfoveal | 0.7 | 0.8 | 87 | 94 | 0.19 | 0.18 | Unchanged | 3.5 |
| 7/F/48 | 9 | R | −17.50 | Subfoveal | 0.4 | 0.4 | 309 | 293 | 1.67 | 1.38* | Reduced | 4 |
| 8/F/57 | 3 | R | −15.50 | Juxtafoveal | 0.2 | 0.35* | 234 | 244 | 0.97 | 0.94 | Reduced | 4 |
D, diopters; Duration, duration of symptoms before treatment; F, female; M, male; R, right; L, left; Refraction, spherical equivalent refraction; Pre, pretreatment.
*BCVA improved to more than two lines, foveal thickness and CNV size decreased by more than 10%.
†The refraction before cataract surgery.